A Win For Novus Therapeutics, Inc.

Tue 15 Sep 20 at 05:30 PM
A Win For Novus Therapeutics, Inc.

Novus Therapeutics, Inc. (NVUS:NASDAQ) shot up at $1.11, a gain of 192.9%. On Mon 14 Sep 20, NVUS:NASDAQ touched a New 2-Week Intraday Low of $0.35. The stock appeared on our News Catalysts scanner on Tue 15 Sep 20 at 05:29 PM in the 'MISCELLANEOUS' category. From Mon 31 Aug 20, the stock recorded 11.11% Up Days and 10.00% Green Days

The stock spiked on Wed 22 Jul 20 at $0.61 with a volume of 2M+, and its share price has been moving sideways in recent weeks.

About Novus Therapeutics, Inc. (NVUS:NASDAQ)

Novus Therapeutics Inc is a pharmaceutical company focusing on the acquisition, development, and commercialization of ear, nose, and throat products. Its technologies have the potential to be developed for multiple ENT indications.

Share